Blood thinner bivalirudin is more effective than heparin with optional use of glycoprotein IIb/IIIa inhibitors in reducing risk of death and major bleeding complications in patients with ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) in a pre-hospital setting, a new study reveals. Findings from the EUROMAX trial were reported today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored ...
via Medindia Health News
More READ 
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/11/pre-hospital-administration-of.html
No comments:
Post a Comment